Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease
autor
Wallentin, Lars
Held, Claes
Armstrong, Paul W.
Cannon, Christopher Paul
Davies, Richard Y.
Granger, Christopher B.
vastutusandmed
Lars Wallentin, Claes Held, MD, Paul W. Armstrong, Christopher P. Cannon, Richard Y. Davies, Christopher B. Granger, Emil Hagström, Robert A. Harrington, Judith S. Hochman, Wolfgang Koenig, Sue Krug‐Gourley, Emile R. Mohler, Agneta Siegbahn, Elizabeth Tarka, Philippe Gabriel Steg, Ralph A. H. Stewart, Robert Weiss, Ollie Östlund, Harvey D. White, Andrzej Budaj, Diego Ardissino, Alvaro Avezum, Philip E. Aylward, Alfonso Bryce, Hong Chen, Ming‐Fong Chen, Ramon Corbalan, Anthony J. Dalby, Nicolas Danchin, Robbert J. De Winter, Stefan Denchev, Rafael Diaz, Moses Elisaf, Marcus D. Flather, Assen R. Goudev, Liliana Grinfeld, Steen Husted, Hyo‐Soo Kim, Ales Linhart, Eva Lonn, José López‐Sendón, Athanasios J. Manolis, José C. Nicolau, Prem Pais, Alexander Parkhomenko, Terje R. Pedersen, Daniel Pella, Marco A. Ramos‐Corrales, Mikhail Ruda, Mátyás Sereg, Saulat Siddique, Peter Sinnaeve, Piyamitr Sritara, Henk P. Swart, Rody G. Sy, Tamio Teramoto, Hung‐Fat Tse, W. Douglas Weaver, Margus Viigimaa, Dragos Vinereanu, and Junren Zh
kirjastus/väljaandja
ajakirja aastakäik number kuu
vol. 5, 6
ilmumisaasta
leheküljed
art. e003407
võtmesõna
ISSN
2047-9980
märkused
Bibliogr.: 32 ref
Open Access
Open Access
teaduspublikatsioon
teaduspublikatsioon
klassifikaator
kategooria (üld)
kategooria (alam)
kvartiil
TTÜ struktuuriüksus
keel
inglise
Wallentin, L., Held, C., Armstrong, P.W., Cannon, C.P., Davies, R.Y., Granger, C.B., Hagström, E., Harrington, R.A., Viigimaa, M. et al. Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease // Journal of the American Heart Association (2016) vol. 5, 6, art. e003407.